Assessment of Public Opinion on Transparency at the US Food and Drug Administration

被引：3
|
作者：
Azad, Tej D. [1 ]
Plott, Caroline F. [2 ]
Gielen, Andrea C. [3 ]
Sharfstein, Joshua M. [4 ]
机构：
[1] Johns Hopkins Univ Hosp, Dept Neurosurg, Baltimore, MD 21287 USA
[2] Johns Hopkins Sch Med, Baltimore, MD USA
[3] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA
[4] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, 615 N Wolfe St,W1033F, Baltimore, MD 21205 USA
来源：
JAMA NETWORK OPEN | 2022年 / 5卷 / 02期
关键词：
D O I：
10.1001/jamanetworkopen.2022.0026
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：6
相关论文
共 50 条
  • [41] Integrated Drug Reviews at the US Food and Drug Administration Reply
    Doshi, Peter
    Morten, Christopher J.
    Herder, Matthew
    JAMA INTERNAL MEDICINE, 2020, 180 (09) : 1261 - 1262
  • [42] The Food and Drug Administration -A Protector of Public Health
    Mintener, Bradshaw
    PUBLIC HEALTH REPORTS, 1955, 70 (11) : 1099 - 1103
  • [43] Some US Food and Drug Administration perspectives on data mining for pediatric safety assessment
    O'Neill, RT
    Szarfman, A
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2001, 62 (09): : 650 - 663
  • [44] Perspective of the US Food and Drug Administration on concomitant administration of Zostavax and Pneumovax
    Baylor, Norman W.
    VACCINE, 2011, 29 (48) : 8771 - 8771
  • [45] US Food and Drug Administration Clinical Investigator Inspections
    Buchmeier, Andrea D.
    SEMINARS IN ONCOLOGY NURSING, 2020, 36 (02)
  • [46] The History of Dermatology and Dermatologists at the US Food and Drug Administration
    Burrows, Vanessa L.
    Luke, Markham C.
    DERMATOLOGIC CLINICS, 2022, 40 (03) : 237 - 248
  • [47] The US Food and Drug Administration and the Future of Cardiovascular Medicine
    Fiuzat, Mona
    Califf, Robert M.
    JAMA CARDIOLOGY, 2016, 1 (08) : 950 - 952
  • [48] US Food and Drug Administration approval of esketamine and brexanolone
    Cristea, Ioana A.
    Naudet, Florian
    LANCET PSYCHIATRY, 2019, 6 (12): : 975 - 977
  • [49] What about the role of the US food and drug administration?
    Bigby, BG
    Bigby, TD
    CHEST, 2002, 122 (05) : 1869 - 1870
  • [50] Recalls of foods and cosmetics by the US Food and Drug Administration
    Venugopal, R
    Tollefson, L
    Hyman, FN
    Timbo, B
    Joyce, RE
    Klontz, KC
    JOURNAL OF FOOD PROTECTION, 1996, 59 (08) : 876 - 880
12345